CompletedNot applicableNCT00584948
Memantine Treatment in Fragile X-Associated Tremor/Ataxia Syndrome
Studying Fragile X-associated tremor/ataxia syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of California, Davis
- Principal Investigator
- Randi J Hagerman, MD, M.DUniversity of California, Davis
- Intervention
- Memantine(drug)
- Enrollment
- 94 enrolled
- Eligibility
- 30-80 years · All sexes
- Timeline
- 2007 – 2012
Study locations (2)
- UC Davis MIND Institute, Sacramento, California, United States
- University of Colorado Health Sciences Center, Aurora, Colorado, United States
Collaborators
National Institute on Aging (NIA) · Forest Laboratories
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00584948 on ClinicalTrials.gov